Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc.（CRDL.TO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
crdl.to · 股价预测 · 3 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 3 位华尔街分析师
Buy
3 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.58
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.50 | ↓ 5.00% |
1-day model range: $1.49–$1.51. Peak: $1.51 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -25.6% |
| 2028 | $1 | -35.1% |
| 2029 | $1 | -39.3% |
| 2030 | $1 | -41.2% |
| 2031 | — | -42.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CRDL.TO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Cardiol Therapeutics Inc. (CRDL.TO) stock. Of the recent 17 rating actions, 0 were upgrades and 0 were downgrades. 3 analysts currently cover CRDL.TO.
分析师推荐趋势
CRDL.TO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2M
↓ 96.9% YoY
Revenue Next Year
$4M
↑ 176.1% YoY
EPS This Year
$-0.47
EPS Next Year
$-0.23
↓ 52.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRDL.TO EPS of $-0.47 for the current fiscal year, based on estimates from 4 analysts. The CRDL.TO revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CRDL.TO 股价预测由两类独立数据源支撑：来自 3 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CRDL.TO 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
CRDL.TO 的短期预测（明日）为 $1.50（-5.00%）。 CRDL.TO 对 2027 年的股价预测均值为 $1。 CRDL.TO 对 2030 年的预测区间为 $1–$1。
Cardiol Therapeutics Inc. 在 TSX 上市，代码 CRDL.TO。CRDL.TO 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CRDL.TO 预测 · 8 个问题根据 3 位华尔街分析师，CRDL.TO 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $1.58，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.